Thousands of cancer sufferers are set to be denied a 'miracle' drug on the NHS that is routinely used in virtually every other Western country.
The Government's rationing body says Avastin is not cost-effective despite evidence that it can prolong the lives of bowel cancer patients by more than two years.
The final decision is due next month, but NICE, the National Institute for Health and Clinical Excellence, has already made clear the cost breaches its threshold for NHS use.
Thursday, May 06, 2010
Britain already has a death panel. It's called NICE